Back to Search
Start Over
Ethionamide induced blue vision (cyanopsia): Case report
- Source :
- Indian Journal of Tuberculosis. 67:333-335
- Publication Year :
- 2020
- Publisher :
- Elsevier BV, 2020.
-
Abstract
- Ethionamide is part of a group of drugs used in the treatment of drug resistant TB. With the advent of increasing drug resistance in pulmonary TB cases, use of Ethionamide, a second line anti tubercular drug is increasing. Vision changes are rare with ethionamide. Cyanopsia i.e., bluish tinted vision of surroundings with ethionamide is not known in literature. Here, we report a case of DRTB patient who developed cyanopsia soon after introducing ethionamide. Although reversible, ethionamide may sometimes need withdrawal because of significant distress caused to patient.
- Subjects :
- Drug
medicine.medical_specialty
Tuberculosis
genetic structures
media_common.quotation_subject
Moxifloxacin
Antitubercular Agents
Color Vision Defects
Drug resistance
Young Adult
03 medical and health sciences
Kanamycin
Tuberculosis, Multidrug-Resistant
medicine
Humans
Ethionamide
Anti tubercular
media_common
0303 health sciences
030306 microbiology
business.industry
Drug resistant tuberculosis
Linezolid
medicine.disease
Cyanopsia
Aminosalicylic Acid
Dermatology
Infectious Diseases
Cycloserine
Female
Pulmonary tb
business
medicine.drug
Subjects
Details
- ISSN :
- 00195707
- Volume :
- 67
- Database :
- OpenAIRE
- Journal :
- Indian Journal of Tuberculosis
- Accession number :
- edsair.doi.dedup.....53417240802dab3881bb03a2bdca77a8